An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC
Clinical trial NCT05800080 · UNKNOWN
Trial details
- NCT number
- NCT05800080
- Sponsor
- Xijing Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2024-02-01
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.